Shine-On BioMedical (6926.TWO) Earnings Analysis
Shine-On BioMedical (6926.TWO) has no confirmed upcoming earnings date. Trailing P/E -28.42.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6926.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 6926.TWO. This page updates as the calendar is published.
6926.TWO earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
6926.TWO valuation and analyst view
| Trailing P/E | -28.42 |
|---|---|
| Trailing EPS | -2.21456 TWD |
| Price / book | 3.46 |
| Dividend yield | 0.00% |
| Market cap | 3.22B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shine-On BioMedical (6926.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 6926.TWO. This page updates as the calendar is published.
What is 6926.TWO's current P/E ratio and EPS?
6926.TWO trades at a trailing P/E of -28.42 on trailing EPS of -2.214558232931727 TWD.
What do analysts rate 6926.TWO?
6926.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.